Argan
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 months.
- Recent price momentum is -35.8% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 6.4% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 21.2x | Better than 39% |
| Forward P/E | 22.6x | Better than 29% |
| Price / Sales | 3.6x | Better than 33% |
| P/E vs own 5-yr range | 45th pctl | Better than 64% |
Growth A+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 27.6% | Better than 89% |
| Net income CAGR (3Y) | 60.9% | Better than 90% |
| Free cash flow CAGR (3Y) | 81.4% | Better than 91% |
Profitability B+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 20.5% | Better than 19% |
| Operating margin | 14.3% | Better than 63% |
| Net margin | 14.6% | Better than 70% |
| Return on equity | 33.8% | Better than 90% |
| Return on invested capital | 33.6% | Better than 97% |
Momentum D
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -46.4% | Better than 7% |
| 6-month return | -59.0% | Better than 5% |
| 12-month return (ex latest month) | -1.0% | Better than 33% |
| Distance below 52-week high | 66.5% | Better than 7% |
Financial Health A+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.6x | Better than 44% |
| Debt to assets | 0.2% | Better than 97% |
| Interest coverage | 488.0x | Better than 97% |
| Free cash flow / net income | 298.2% | Better than 86% |
Analyst View A-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 80.0% | Better than 58% |
| Upside to average target | 117.4% | Better than 87% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 295.85
- Open
- 286.43
- Day range
- 263.46 - 287.94
- Avg price
- 270.41
- Volume
- 376.82K
- Turnover
- 101.89M
- Turnover ratei
- 2.74%
- Volume ratioi
- 1.52
- Amplitudei
- 8.27%
- 52-week rangei
- 252.88 - 803.46
Valuation
- P/Ei
- 27.61
- P/E (TTM)i
- 21.24
- P/Bi
- 7.44
- EPSi
- 9.74
- Book value / shi
- 36.13
- Net profit
- 136.65M
- Net assets
- 506.84M
Share structure
- Market cap
- 3.77B
- Float capi
- 3.71B
- Shares out
- 14.03M
- Float sharesi
- 13.78M
Dividend & listing
- Div yield (TTM)i
- 0.74%
- Dividend (TTM)
- 2.00
- Listing date
- 1970-01-01
66.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+1.81M net over the window
Short interest
- Shares short
- 896.06K
- % of floati
- 6.39%
- Days to coveri
- 3.05
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Argan (AGX)?
Argan last traded at 268.94. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Argan's market cap?
About 3.77B.
What is the P/E ratio of Argan?
The trailing twelve-month P/E is 21.24, below its own 5-year average of 28.21 — in the middle of its historical range (44.58% percentile). See the Valuation tab for the full history.
Does Argan pay a dividend?
Yes. The trailing dividend yield is 0.74%. The 2025 payout was up 27.5% from 2024. See the Dividends tab for the full payment history.
Is Argan a buy according to analysts?
The consensus of 5 analysts is a Buy rating, with an average 12-month price target of 584.60, which implies 117.4% upside from the current price. This is not investment advice.
What is Argan's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Argan a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 20:02:35 · For reference only, not investment advice and not tailored to your situation.
Argan discussion 0 comments